Copertina

Socio‐economic inequalities in second primary cancer incidence: A competing risks analysis of women with breast cancer in England between 2000 and 2018

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ruchika Golani, Eva Kagenaar, Jérémie Jégu, Aurélien Belot, Suping Ling
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	International Journal of Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Routine estradiol testing recommended for women at high risk of breast cancer
di: Mary Beth Nierengarten
Pubblicazione: (2024)

Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors
di: Carolyn Brandt, et al.
Pubblicazione: (2024)

Mammographic density and breast cancer risk among Black American women
di: Etienne X. Holder, et al.
Pubblicazione: (2024)

The long road to unbiased estimates of pancreatic cancer incidence in the hereditary breast and ovarian cancer syndrome
di: Neha Hippalgaonkar, et al.
Pubblicazione: (2025)

Renal cell carcinoma and risk of second primary cancer: A Danish nationwide cohort study
di: Maria B. Bengtsen, et al.
Pubblicazione: (2024)

Considerations for multidisciplinary management of synchronous primary breast cancer and primary lung cancer – Analysis of thirty‐one patients
di: Xue Chen, et al.
Pubblicazione: (2024)

Statin use and risks of breast cancer recurrence and mortality
di: Hanbing Guo, et al.
Pubblicazione: (2024)

Examining inequities associated with incarceration among breast cancer patients
di: Yoshiko Iwai, et al.
Pubblicazione: (2024)

Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status
di: Sara Nofal, et al.
Pubblicazione: (2025)

Diagnostic challenge and survival analysis of pulmonary oligometastases and primary lung cancer in breast cancer patients
di: Siyao Mai, et al.
Pubblicazione: (2024)

Risk of second primary malignancies after adjuvant chemotherapy for colon cancer
di: Tomas Buchler, et al.
Pubblicazione: (2025)

Poverty in the residential and surrounding counties and its impact on mortality in women with breast cancer
di: Ifeoma Nwigwe, et al.
Pubblicazione: (2026)

Preference for breast cancer screening in Chinese women: Discrete choice experiment
di: Shuning Wu, et al.
Pubblicazione: (2025)

Inflammation and dimensions of fatigue in women with early stage breast cancer: A longitudinal examination
di: Julienne E. Bower, et al.
Pubblicazione: (2025)

The landscape of chemotherapy modifications among women treated for stage I–IIIA breast cancer
di: Jenna Bhimani, et al.
Pubblicazione: (2026)

An analysis of multilevel factor contributions to breast cancer screening inequities in an academic health system
di: Leah M. Marcotte, et al.
Pubblicazione: (2025)

Trends in breast cancer incidence by estrogen receptor status in the United States , 2004–2020
di: Chenxi Jiang, et al.
Pubblicazione: (2024)

Trends in the incidence of cancers of the breast and female genital tract in Harare, Zimbabwe 1990–2019
di: Eric Chokunonga, et al.
Pubblicazione: (2026)

Population‐specific validation and comparison of the performance of 77‐ and 313‐variant polygenic risk scores for breast cancer risk prediction
di: Milena Hovhannisyan, et al.
Pubblicazione: (2024)

Disparities in cancer incidence by sexual orientation
di: Aimee K. Huang, et al.
Pubblicazione: (2024)

Metformin and other anti‐diabetic medication use and breast cancer incidence in the Nurses' Health Studies
di: Tengteng Wang, et al.
Pubblicazione: (2024)

Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors
di: Rikesh Bhatt, et al.
Pubblicazione: (2024)

Body mass index and breast cancer risk among postmenopausal women with and without cardiometabolic diseases: Findings from two prospective cohort studies in Europe
di: Emma Fontvieille, et al.
Pubblicazione: (2025)

Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer
di: Zhuang Li, et al.
Pubblicazione: (2025)

Incidence of late recurrence and second primary cancers 5–10 years after non‐metastatic colorectal cancer
di: Jesper Nors, et al.
Pubblicazione: (2024)

Antibody–drug conjugates in breast cancer
di: Elizabeth A. Sakach, et al.
Pubblicazione: (2026)

Lobular breast cancer statistics, 2025
di: Angela N. Giaquinto, et al.
Pubblicazione: (2025)

High accuracy in detecting HER2‐low status in FNA of primary and metastatic breast cancer
di: Giuseppe D’Abbronzo, et al.
Pubblicazione: (2026)

Education level and risk of breast cancer by tumor subtype in the EPIC cohort
di: Margherita Pizzato, et al.
Pubblicazione: (2025)

Cardiovascular disease incidence and cancer risk in two large European prospective cohorts
di: Emma Fontvieille, et al.
Pubblicazione: (2026)

Preferences of BRCA mutation carriers for attributes of risk‐reducing surgical options for breast and ovarian cancer
di: Katherine C. Fitch, et al.
Pubblicazione: (2025)

Patient factors and modifications to intended chemotherapy for women with Stages I–IIIA breast cancer
di: Jenna Bhimani, et al.
Pubblicazione: (2025)

Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000–2021
di: Jaclyn LoPiccolo, et al.
Pubblicazione: (2025)

Global incidence, risk factors, and temporal trends of nasal cancer: A population‐based analysis
di: Junjie Huang, et al.
Pubblicazione: (2025)

Trends in breast, colon, pancreatic, and uterine cancers in women during the COVID‐19 pandemic in North Carolina
di: Sarah J. Nyante, et al.
Pubblicazione: (2024)

Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology
di: Shu Qin Wei, et al.
Pubblicazione: (2025)

FDA approves capivasertib with fulvestrant for breast cancer
di: Mary Beth Nierengarten
Pubblicazione: (2024)

Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial
di: Neil M. Iyengar, et al.
Pubblicazione: (2024)

Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy
di: Helen M. Johnson, et al.
Pubblicazione: (2024)

Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry
di: Lydia G. van der Geest, et al.
Pubblicazione: (2025)